Skip to main content
T

TISSUE REPAIR LTD — Investor Relations & Filings

Ticker · TRP ISIN · AU0000180887 ASX Professional, scientific and technical activities
Open in API
Filings indexed 27 across all filing types
Latest filing 2026-04-29 Regulatory Filings
Country AU Australia
Listing ASX TRP

About TISSUE REPAIR LTD

https://tissuerepair.com.au/

Tissue Repair Ltd is a clinical-stage biopharmaceutical company focused on the development of advanced wound healing and skin repair agents. The company’s core technology centers on Glucoprime, a proprietary yeast-derived beta-glucan designed to stimulate the innate immune system and accelerate the body's natural healing processes. Its lead candidate, TR-987, is being developed for the treatment of chronic wounds, such as venous leg ulcers, and for use in post-procedural recovery following aesthetic treatments. By targeting the inflammatory phase of wound healing, the technology aims to improve clinical outcomes and reduce recovery times. The company focuses on addressing unmet needs in both the medical wound care and cosmetic dermatology markets through its specialized biological platform.

Recent filings

Filing Released Lang Actions
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 436.1KB
Regulatory Filings
2026-04-29 English
Director Appointment 1 page 232.0KB
Board/Management Information Classification · 1% confidence The document is an ASX announcement titled “Director Appointment” and details the appointment of Mr Peter Scutt as an Executive Director, including his consultancy agreement terms and biography. This clearly falls under announcements of changes in the company’s board or senior management, matching the Board/Management Information category (MANG).
2026-04-19 English
Initial Director's Interest Notice - PS 2 pages 1.1MB
Director's Dealing Classification · 1% confidence The document is an Appendix 3X “Initial Director’s Interest Notice” filed under ASX Listing Rule 3.19A.1, detailing a director’s relevant interests in securities (unlisted options and fully paid ordinary shares) and contractual interests. This is a classic insider transaction disclosure by a director. It falls under “Director's Dealing” filings.
2026-04-19 English
Notification of cessation of securities - TRP 5 pages 16.5KB
Regulatory Filings
2026-03-02 English
Appendix 4D and Half Year Report to 31 December 2025 20 pages 1.0MB
Regulatory Filings
2026-02-26 English
Notification regarding unquoted securities - TRP 7 pages 23.4KB
Regulatory Filings
2026-02-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.